Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
START Midwest, Grand Rapids, Michigan NYU Langone, New York, New York Tennessee Oncology, Nashville, Tennessee NEXT Oncology Texas, Austin, Texas START Mountain Region, West Valley City, Utah NEXT Oncology Virginia, Fairfax, Virginia